PPA 904
Alternative Names: PPA 904 PDT; PPA 904 photodynamic therapyLatest Information Update: 23 Jun 2015
Price :
$50 *
At a glance
- Originator Photopharmica
- Class Antibacterials; Oxidants; Phenothiazines
- Mechanism of Action Photosensitisers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Acne; Diabetic foot ulcer; Leg ulcer; Leishmaniasis; Wounds
Most Recent Events
- 19 Jan 2009 Photopharmica initiates a phase II trial in patients with chronic venous Leg ulcer in United Kingdom
- 20 Mar 2007 Phase-II clinical trials in Diabetic foot ulcer in United Kingdom (Topical)
- 20 Mar 2007 Preclinical trials in Acne in United Kingdom (Topical)